Mark Ghiglieri |
| Founder & CEO |
| Masterpiece Investments Corporation, Oregon |
|
United States |
About Mark Ghiglieri
An accomplished entrepreneur, Mr. Mark Ghiglieri possesses decades of extensive business leadership experience. The son of famed painter Lorenzo Ghiglieri, Mark Ghiglieri commenced his professional career by working with his father to market his paintings and sculptures. Deeply familiar with his father’s process, Mark Ghiglieri was perfectly equipped to sell his art to a wide range of buyers. The Ghiglieri family’s sense of duty to the community also instilled in Mark Ghiglieri a deep commitment to helping others. This dedication has been manifested in a variety of projects throughout Mark Ghiglieri’s professional career.
Several years later, Mark Ghiglieri established his first business, called Millennium Fine Arts. Basing his business out of Oregon, Mark Ghiglieri, along with investor Phillip Morse, purchased his father’s existing bronze mold collection, along with the rights to reproduce a number of his father’s paintings. Under Mark Ghiglieri’s keen management, the company grew to employ a team of 35.
Two years after selling his interest in Millennium Fine Arts, Mark Ghiglieri attended a charity art auction, where one of his father’s sculptures sold for $63,000. Fueled by the idea of using art to help others, Mark Ghiglieri combined his business endeavors with his philanthropic passions to create Provenance Fine Art. Through his role with Provenance Fine Art, Mark Ghiglieri developed a unique business plan that involved donating pieces of art to charities. Mark Ghiglieri led his company to increasing success, participating in over 500 auctions per month and selling thousands of sculptures.
Today, Mark Ghiglieri is the founder and CEO of Masterpiece Investments Corporation. Combining his family’s talent with his own conceptual ideas, Masterpiece Investments provides beautifully rendered bronze and pure silver sculptures to buyers. Continuing his passion for helping others, Mark Ghiglieri manages the charitable arm of the company, which donates sculptures to nonprofit charities across the nation.
Among the charities that have benefitted from Mark Ghiglieri’s generosity are the American Cancer Society, the Red Cross, the Cystic Fibrosis Foundation, and the Make-A-Wish Foundation, among others.
Currently residing in Naples, Florida, Mark Ghiglieri enjoys spending time with family and friends, playing sports, and helicopter flying. Mark Ghiglieri is currently working on his autobiography, Raised on Adrenaline.
Mark Ghiglieri Links
About Masterpiece Investments Corporation, Oregon
Masterpiece Investments: The Cystic Fibrosis Foundation
As part of its charitable efforts, Masterpiece Investments has donated sculptures to the Cystic Fibrosis Foundation and other non-profit organizations. The Cystic Fibrosis Foundation is supported by donors and volunteers who work to develop a cure for cystic fibrosis, as well as improve the quality of life for those who suffer from the disease. The Foundation funds and accredits over 115 cystic fibrosis care centers, 95 adult care programs, and 50 affiliate programs, making it the leading cystic fibrosis care center in the United States. With 80 chapters and branches across the nation, CFF is a large, but efficient organization whose business model has been recognized by Forbes, The Wall Street Journal, BusinessWeek, The New York Times, and the National Institute of Health. In addition to raising the funds needed to pioneer a cure for cystic fibrosis, CFF also promotes advancements in cystic fibrosis research through government and industry channels; links patients and families to cystic fibrosis specialists; and provides support, information, and resources to those battling the disease. When CFF was founded in 1955, children diagnosed with cystic fibrosis were predicted to live only a few years. The predicated median survival age is now 37 years, due in large part to the Foundation’s efforts toward aggressive and innovative research as well as comprehensive care. CFF has directly assisted in the discovery of the defective gene that causes cystic fibrosis and has also played a key role in the creation and approval of four routine cystic fibrosis therapies. At present, research into over 30 potential new treatments is being supported by CFF. In cooperation with FoldRX Pharmaceuticals, CFF is currently donating $22 million over five years toward the discovery and development of new treatment compounds. Cystic fibrosis causes the buildup of mucus in the body that clogs organs, including the lungs and pancreas, and traps bacteria, leading to infection. Cystic fibrosis is a genetic disorder currently affecting 30,000 children and adults in the United States alone. About one in every 31 Americans is a carrier of the defective cystic fibrosis gene.